contract manufacturing news from FiercePharma
News
IMS: Pace of outsourcing accelerating
Drugmakers are pulling out of manufacturing at an unprecedented rate, according to a new report from IMS Health. Four of the top Read more...
CMOs growing 14 percent annually
With Big Pharma cutting back, CMOs are picking up the slack. The worldwide market for biopharmaceutical contract manufacturing reached $2.4 billion in 2007, a year-over-year leap of 14 percent, and Read more...
AZ reaffirms whole-hog API outsourcing
Remember last fall when AstraZeneca EVP David Smith said the company was looking to outsource most of its Read more...
New companies flooding CMO market
More evidence that biologic drugs are where it's at: Experts are predicting tough times ahead for contract manufacturers that focus too closely on Big Pharma's bread-and-butter small-molecule Read more...
SPOTLIGHT: Hikal wins Pfizer manufacturing deal
An Indian contract manufacturing company is jumping for joy after Pfizer chose it as a supplier of active pharmaceutical ingredients. Hikal will make the APIs at its FDA-approved manufacturing plant Read more...
Pharma feeds contract manufacturing
Big Pharma announced thousands of layoffs in 2007. Companies have already started passing out pink slips. But a flurry is Read more...
ALSO NOTED: JHP takes over King Pharma plant; AstraZeneca expands giveaway program
> King Pharma sold off its Rochester, Michigan, manufacturing plant to JHP Pharmaceuticals for $93 million in cash; JHP will take on the plant employees and contract manufacturing there. Read more...
AstraZeneca to outsource manufacturing
How many drugs would a drugmaker make if a drugmaker didn't make drugs? More, says AstraZeneca, or at least more profitable ones. The company is planning to outsource its manufacturing--all of Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends